Permanent Canonical ID: HTA-0332
Legacy Pilot ID: _(none)_
Original Transcript: medical stories.txt
Source Folder: WRC:NBC
| Field | Value |
|---|---|
| Canonical Story ID | HTA-0332 |
| Canonical Title | Medical Stories: Four Reports from the Frontiers of Medicine |
| Original Transcript | medical stories.txt |
| Alternate Transcripts | _(none)_ |
| Field | Value |
|---|---|
| Broadcast Era | Washington DC (WRC-TV) (confidence: 98%) |
| Station | WRC-TV Channel 4 (confidence: 98%) |
| Program | NewsCenter 4 |
| Approximate Year | 1984–1987 (confidence: 75%) |
| Exact Date | Unknown (multiple broadcast dates — compilation) |
| Story Type | Compilation of 4 separate medical features |
| Duration | ~12.5 minutes total |
Dating Clues: Sign-off is "Henry Tenenbaum, Channel 4 News" (each story). TPA (tissue plasminogen activator) was in clinical trials in the mid-1980s (FDA approved 1987). CVS (chorionic villi sampling) was introduced in the US in the early-to-mid 1980s. These place the stories in approximately 1984–1987. This compilation likely represents Henry's medical reporting portfolio during his documented role as WRC medical reporter (confirmed by HACD-0108, the AIDS coverage article).
Opening Hook: Each story opens with a patient in crisis or at a medical crossroads, grounding complex science in human stakes.
One-Sentence Summary: Four separate medical features demonstrate Henry's rigorous science journalism at WRC-TV, covering barbiturate coma therapy, hospital cost reduction, experimental clot-dissolving drugs, and prenatal genetic testing.
Expanded Summary:
Story 1 — Barbiturate Coma (Johns Hopkins): Terry Murray, 20, lies in a barbiturate-induced coma at Johns Hopkins neurosciences critical care unit. Henry explains how doctors deliberately suppress brain activity to reduce blood flow and prevent secondary damage after traumatic brain injury. The piece balances the technical explanation with the human drama of a young person's life hanging in the balance.
Story 2 — Hospital Cost Reduction: Dr. Paul Corso has developed a cost analysis program that identifies unnecessary medical procedures. Patient Grace Kraviritas undergoes bypass surgery while Henry tracks the specific savings: $662 from eliminated pulmonary lab tests, $471 from operating room efficiencies, $186 from blood services, $887 from reduced ICU time — totaling over $2,200 per patient. The piece makes the abstract problem of healthcare costs concrete through one patient's journey.
Story 3 — TPA (Tissue Plasminogen Activator): Dr. Michael Schaefer, a George Washington University employee, suffers a heart attack and becomes a patient in his own hospital's experimental TPA trial. Dr. Alan Ross, GWU's cardiology director, explains how TPA dissolves blood clots twice as effectively as streptokinase. Henry notes TPA is available at only 13 medical centers nationwide, making this both a science story and a healthcare access story.
Story 4 — CVS (Chorionic Villi Sampling): Tim and Georgiana Knott await results of a new prenatal genetic test that delivers answers in 24 hours rather than the three weeks required by amniocentesis. Dr. Joseph Schulman at the Genetics and IVF Institute in Fairfax performs the procedure. Henry follows the Knotts through the waiting period to the birth of their healthy son, Nathan Thomas. Cost: $750–$900. The piece ends with anchor banter, demonstrating Henry's easy transition between serious reporting and collegial warmth.
Themes: Medical Innovation, Healthcare Costs, Patient Stories, Science Journalism, Access to Care, Hope
Skills Demonstrated: Complex topic explanation, Patient-centered storytelling, Data-driven reporting, Science journalism, Anchor rapport
Historical/Cultural Context: The mid-1980s were a period of rapid medical innovation alongside growing concern about healthcare costs. Henry's medical reporting at WRC — confirmed by external documentation of his AIDS coverage — placed him at the intersection of these two trends. TPA would go on to revolutionize heart attack treatment after FDA approval in 1987. CVS became a standard prenatal testing option. These stories captured emerging technologies at the moment they were transitioning from experimental to clinical.
| Name | Role |
|---|---|
| Henry Tenenbaum | Reporter |
| Terry Murray | Subject — brain injury patient (age 20) |
| Dr. Paul Corso | Interviewee — cost analysis researcher |
| Grace Kraviritas | Subject — bypass surgery patient |
| Dr. Michael Schaefer | Subject — GWU employee, heart attack patient |
| Dr. Alan Ross | Interviewee — GWU cardiology director |
| Dr. Joseph Schulman | Interviewee — Genetics and IVF Institute |
| Tim Knott | Interviewee — expectant father |
| Georgiana Knott | Interviewee — expectant mother |
| Pat Kent | Interviewee — CVS patient |
| Jean Wolfe | Referenced — nurse practitioner |
| Name | Relationship |
|---|---|
| Johns Hopkins Hospital | Location — Story 1 |
| George Washington University Medical Center | Location — Story 3 |
| Genetics and IVF Institute (Fairfax) | Location — Story 4 |
| WRC-TV Channel 4 | Broadcast outlet |
Places: Johns Hopkins Hospital (Baltimore), George Washington University Medical Center, Genetics and IVF Institute (Fairfax Hospital), Washington DC
Countries: United States
Tags: medical reporting, TPA, CVS, barbiturate coma, hospital costs, Johns Hopkins, GWU, Fairfax, prenatal testing, heart attack, brain injury, Channel 4 News, science journalism, healthcare access
_(Reserved for future editorial review)_
| Field | Value |
|---|---|
| Media Exists | Audio transcript preserved |
| Media Location | Source Repository / WRC:NBC folder |
| Preservation Status | Transcript preserved; original tape status unknown |
This section is reserved for Henry's personal annotations.
The AI must never modify, summarize, rewrite, or delete anything in this section
unless explicitly instructed by Henry.